Recently, Dr. Verkman and his colleagues screened small molecules for pendrin inhibitors and showed that several pendrin inhibitor compounds significantly increased airway surface liquid thickness in cystic fibrosis patient bronchial epithelial cells expressing high levels of pendrin 19. This evidence concerns the gene SLC26A4 and cystic fibrosis.